Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
RESEARCH TOOLSreports
Holding ARQT?
Track your performance easily
See the Price Targets and Ratings of:
ARQT Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ARQT Stock 12 Month Forecast
Average Price Target
$19.00
▲(27.86% Upside)
| Highest Price Target$20.00 | Average Price Target$19.00 | Lowest Price Target$18.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Mizuho Securities
Reiterated
12/13/24
TD Cowen
Reiterated
11/11/24
Needham
Reiterated
11/07/24
Morgan Stanley
Reiterated
11/07/24
Jefferies
$15
Buy
0.94%
Upside
Assigned
08/28/24
Buy Rating Initiated on Arcutis Biotherapeutics Amidst Zoryve's Market Expansion and Promising Sales Trajectory
Goldman Sachs
$12
Hold
-19.25%
Downside
Reiterated
08/15/24
Arcutis Biotherapeutics: Hold Rating with Cautious Optimism Amid Mixed Financial Signals
JonesTrading
―
Hold
―
Reiterated
02/27/24
Arcutis Biotherapeutics (ARQT) Gets a Hold from JonesTrading
Best Analysts Covering Arcutis Biotherapeutics
Which Analyst Should I Follow If I Want to Buy ARQT and Sell After:
1 Month
xxx
Success Rate
10/18 ratings generated profit
Average Return
+2.72%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +2.72% per trade.
3 Months
xxx
Success Rate
9/18 ratings generated profit
Average Return
+27.14%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +27.14% per trade.
1 Year
Success Rate
9/18 ratings generated profit
Average Return
+35.59%
reiterated a buy rating last month
Copying Vikram Purohit's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +35.59% per trade.
2 Years
xxx
Success Rate
9/18 ratings generated profit
Average Return
+43.18%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +43.18% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ARQT Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
12
12
8
7
6
Buy
3
5
7
10
10
Hold
1
1
1
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
18
16
17
16
Each month's total comprises the sum of three months' worth of ratings.
ARQT Financial Forecast
ARQT Stock Forecast FAQ
What is ARQT’s average 12-month price target, according to analysts?
Based on analyst ratings, Arcutis Biotherapeutics’s 12-month average price target is $19.00.
What is ARQT’s upside potential, based on the analysts’ average price target?
Arcutis Biotherapeutics has 27.86% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ARQT a Buy, Sell or Hold?
Arcutis Biotherapeutics has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Arcutis Biotherapeutics’s price target?
The average price target for Arcutis Biotherapeutics is $19.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $18.00. The average price target represents 27.86% Increase from the current price of $14.86.
The highest analyst price target is $20.00 ,the lowest forecast is $18.00. The average price target represents 27.86% Increase from the current price of $14.86.
What do analysts say about Arcutis Biotherapeutics?
Arcutis Biotherapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of ARQT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.